These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 12451568)

  • 21. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
    Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
    Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
    Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
    Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus DNA, HPV L1 capsid protein and p16
    Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
    Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of p16INK4A and Hybrid Capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations.
    Nassar A; O'Reilly K; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2008 Mar; 36(3):142-8. PubMed ID: 18232003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of continued upregulation of p16(INK4a) through the evolution from high-grade squamous intraepithelial lesion to invasive squamous carcinoma of the cervix.
    Cheah PL; Looi LM; Mun KS; Abdoul Rahman N; Teoh KH
    Malays J Pathol; 2011 Dec; 33(2):83-7. PubMed ID: 22299207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
    Razmpoosh M; Sansregret A; Oligny LL; Patey N; Dormoy-Raclet V; Ducruet T; Bouron-Dal Soglio D
    Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
    Wang R; Li X; Qian M; Niu J; You Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
    Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of p63 for distinction of glandular versus squamous lesions in cervicovaginal specimens.
    Garcia MT; Acar BC; Jorda M; Gomez-Fernandez C; Ganjei-Azar P
    Cancer; 2007 Feb; 111(1):54-7. PubMed ID: 17173320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
    Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
    Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The triage of low-grade cytological abnormalities by the immunocytological expression of cyclin-dependent kinase inhibitor p16INK4a versus Human Papillomavirus test: a real possibility to predict cervical intraepithelial neoplasia CIN2 or CIN2+.
    Stănculescu R; Brătilă E; Bauşic V; Vlădescu T
    Rom J Morphol Embryol; 2013; 54(4):1061-5. PubMed ID: 24399002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix.
    Nieh S; Chen SF; Chu TY; Lai HC; Fu E
    Gynecol Oncol; 2003 Oct; 91(1):201-8. PubMed ID: 14529682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions.
    Carydis VB; Walker T; Wing A; Colgan TJ
    Acta Cytol; 2007; 51(4):517-22. PubMed ID: 17718114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases].
    Yu J; Zhu HT; Zhao JJ; Su JZ; Xia YD
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):323-326. PubMed ID: 28468038
    [No Abstract]   [Full Text] [Related]  

  • 38. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
    Ishida K; Araki A; Kobayashi M; Taniyama K; Nabika T; Nagasaki M
    Diagn Cytopathol; 2014 Feb; 42(2):125-33. PubMed ID: 23754829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
    Oberg TN; Kipp BR; Vrana JA; Bartholet MK; Fales CJ; Garcia R; McDonald AN; Rosas BL; Henry MR; Clayton AC
    Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Shain AF; Kwok S; Folkins AK; Kong CS
    Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.